loading
Akoya Biosciences Inc stock is traded at $1.35, with a volume of 200.33K. It is down -2.88% in the last 24 hours and down -17.18% over the past month. Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
See More
Previous Close:
$1.39
Open:
$1.42
24h Volume:
200.33K
Relative Volume:
0.33
Market Cap:
$67.25M
Revenue:
$96.63M
Net Income/Loss:
$-63.32M
P/E Ratio:
-0.9247
EPS:
-1.46
Net Cash Flow:
$-54.55M
1W Performance:
-12.34%
1M Performance:
-17.18%
6M Performance:
-52.13%
1Y Performance:
-70.39%
1-Day Range:
Value
$1.34
$1.49
1-Week Range:
Value
$1.32
$1.58
52-Week Range:
Value
$1.32
$4.65

Akoya Biosciences Inc Stock (AKYA) Company Profile

Name
Name
Akoya Biosciences Inc
Name
Phone
855.896.8401
Name
Address
100 CAMPUS DRIVE, MARLBOROUGH
Name
Employee
205
Name
Twitter
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
AKYA's Discussions on Twitter

Compare AKYA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
AKYA
Akoya Biosciences Inc
1.35 67.25M 96.63M -63.32M -54.55M -1.46
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
496.36 177.83B 8.35B 2.32B 1.30B 6.41
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
226.04 66.11B 20.64B 1.73B 2.94B 6.02
Medical Instruments & Supplies icon
ALC
Alcon Inc
92.70 45.85B 9.91B 1.02B 665.00M 2.05
Medical Instruments & Supplies icon
RMD
Resmed Inc
222.30 32.66B 4.93B 1.25B 1.38B 8.47
Medical Instruments & Supplies icon
BAX
Baxter International Inc
34.02 17.45B 17.28B 108.00M 391.00M 0.20

Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-15-24 Downgrade Craig Hallum Buy → Hold
Aug-06-24 Downgrade BTIG Research Buy → Neutral
Aug-06-24 Downgrade JP Morgan Overweight → Neutral
Aug-06-24 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-21-24 Initiated Craig Hallum Buy
Dec-14-23 Initiated Guggenheim Neutral
Jul-05-23 Resumed JP Morgan Overweight
Feb-02-23 Initiated UBS Buy
Nov-03-22 Initiated CapitalOne Overweight
Oct-06-22 Initiated Stephens Overweight
Jun-22-22 Initiated BTIG Research Buy
Jan-06-22 Resumed Piper Sandler Overweight
May-11-21 Initiated Canaccord Genuity Buy
May-11-21 Initiated JP Morgan Overweight
May-11-21 Initiated Morgan Stanley Overweight
May-11-21 Initiated Piper Sandler Overweight
View All

Akoya Biosciences Inc Stock (AKYA) Latest News

pulisher
Mar 30, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 30.8% in March - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Akoya Biosciences stock hits 52-week low at $1.39 amid market challenges By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Akoya Biosciences stock hits 52-week low at $1.39 amid market challenges - Investing.com

Mar 28, 2025
pulisher
Mar 26, 2025

This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Akoya Biosciences’ (AKYA) Equal Weight Rating Reaffirmed at Stephens - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Akoya Biosciences Shares Fall After Downgrade From Stephens - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Stephens Downgrades Akoya Biosciences to Equalweight From Overweight, Price Target is $1.80 - Marketscreener.com

Mar 25, 2025
pulisher
Mar 24, 2025

Tikvah to oppose Quanterix-Akoya Biosciences merger By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Tikvah to oppose Quanterix-Akoya Biosciences merger - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Tikvah Management Announces Intention to Vote AGAINST Quanterix’s Proposed Merger with Akoya Biosciences - Business Wire

Mar 24, 2025
pulisher
Mar 24, 2025

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences - Marketscreener.com

Mar 24, 2025
pulisher
Mar 24, 2025

Key Investor Fights Back: Quanterix Merger Under Fire Over Valuation Concerns - Stock Titan

Mar 24, 2025
pulisher
Mar 24, 2025

Akoya Biosciences (AKYA) to Release Quarterly Earnings on Monday - Defense World

Mar 24, 2025
pulisher
Mar 20, 2025

Akoya Biosciences Reports 2024 Financial Results - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 20, 2025
pulisher
Mar 19, 2025

Akoya Biosciences (NASDAQ:AKYA) Receives Overweight Rating from Stephens - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Akoya Biosciences Shares Down 6.4% After Stock Offering… -June 08, 2023 at 10:10 am EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Akoya Biosciences stock hits 52-week low at $1.43 amid market challenges By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Akoya Biosciences stock hits 52-week low at $1.43 amid market challenges - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

Akoya: Q4 Earnings Snapshot - Milford Mirror

Mar 18, 2025
pulisher
Mar 17, 2025

Akoya Biosciences earnings missed by $0.01, revenue topped estimates - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences, Inc. Q4 Loss Decreases, But Misses Estimates - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences, Inc. SEC 10-K Report - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Kent Lake urges Quanterix to address questions regarding Akoya deal -March 17, 2025 at 04:28 pm EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Amid Pending Acquisition by Quanterix Corporation - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Quanterix Merger Under Fire: Top Investor Reveals Shocking 82% Value Disparity - Stock Titan

Mar 17, 2025
pulisher
Mar 17, 2025

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call - Bluefield Daily Telegraph

Mar 17, 2025
pulisher
Mar 15, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of “Hold” by Brokerages - Defense World

Mar 15, 2025
pulisher
Mar 11, 2025

Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger -March 11, 2025 at 10:40 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Quanterix Merger Under Fire: 7.25% Stakeholder Reveals Shocking Valuation Concerns - StockTitan

Mar 11, 2025
pulisher
Mar 08, 2025

Akoya climbs after merger deal with Quanterix - MSN

Mar 08, 2025
pulisher
Mar 05, 2025

Piper Sandler Downgrades Akoya Biosciences to Neutral From Overweight, Adjusts Price Target to $2.40 From $3 - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

Piper Sandler cuts Akoya Biosciences stock rating to Neutral - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Piper Sandler cuts Akoya Biosciences stock rating to Neutral By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 03, 2025

Quanterix Announces Acquisition of Akoya Biosciences - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Quanterix Highlights Benefits Of Akoya Biosciences Acquisition -March 03, 2025 at 06:13 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Can Quanterix's Akoya Acquisition Transform Biomarker Detection and Deliver $1B Revenue? - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition - Bluefield Daily Telegraph

Mar 03, 2025
pulisher
Mar 02, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 60.1% in February - Defense World

Mar 02, 2025
pulisher
Feb 27, 2025

Akoya Biosciences (AKYA) to Release Earnings on Monday - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Akoya Biosciences’ Merger with Quanterix Moves Forward - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Quanterix advances towards Akoya Biosciences acquisition By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 26, 2025

Akoya Biosciences' Merger with Quanterix Moves Forward By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 25, 2025

Quanterix advances towards Akoya Biosciences acquisition - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

Akoya Biosciences’ Merger with Quanterix Moves Forward By Investing.com - Investing.com UK

Feb 25, 2025
pulisher
Feb 24, 2025

Akoya Biosciences stock hits 52-week low at $1.88 amid market challenges - Investing.com Australia

Feb 24, 2025

Akoya Biosciences Inc Stock (AKYA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$158.08
price down icon 0.49%
$76.34
price up icon 0.39%
$61.38
price down icon 0.63%
medical_instruments_supplies WST
$220.16
price down icon 1.66%
medical_instruments_supplies COO
$81.27
price down icon 3.65%
medical_instruments_supplies BAX
$34.02
price down icon 0.61%
Cap:     |  Volume (24h):